Anne Brita Knapskog
- Senior consultant; MD, PhD
- +47 909 82 548
Publications 2021
Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer's Disease
Front. Aging Neurosci., 12, 608628
DOI 10.3389/fnagi.2020.608628
Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer's disease
Transl. Neurodegener., 10 (1), 18
DOI 10.1186/s40035-021-00244-3
Investigating novel biomarkers of immune activation and modulation in the context of sedentary behaviour: a multicentre prospective ischemic stroke cohort study
BMC Neurol., 21 (1), 318
DOI 10.1186/s12883-021-02343-0
Neopterin and kynurenic acid as predictors of stroke recurrence and mortality: a multicentre prospective cohort study on biomarkers of inflammation measured three months after ischemic stroke
BMC Neurol., 21 (1), 476
DOI 10.1186/s12883-021-02498-w
Neuropsychiatric symptoms and comorbidity: Associations with dementia progression rate in a memory clinic cohort
Int. J. Geriatr. Psychiatr., 36 (6), 960-969
DOI 10.1002/gps.5500
Trajectories and risk factors of dementia progression: a memory clinic cohort followed up to 3 years from diagnosis
Int. Psychogeriatr., 33 (8), PII S1041610220003270-789
DOI 10.1017/S1041610220003270
Associations between post-stroke motor and cognitive function: a cross-sectional study
BMC Geriatr., 21 (1), 103
DOI 10.1186/s12877-021-02055-7
Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke
J. Intern. Med., 289 (3), 355-368
DOI 10.1111/joim.13161
Cerebrospinal Fluid Concentration of Neurogranin in Hip Fracture Patients with Delirium
J. Alzheimers Dis., 81 (2), 667-677
DOI 10.3233/JAD-201341
Working Memory Training in Amnestic and Non-amnestic Patients With Mild Cognitive Impairment: Preliminary Findings From Genotype Variants on Training Effects
Front. Aging Neurosci., 13, 624253
DOI 10.3389/fnagi.2021.624253
Evaluation of semi-quantitative measures of F-18-Flutemetamol PET for the clinical diagnosis of Alzheimer's disease
Quant. Imaging Med. Surg.
DOI 10.21037/qims-21-188
Pre-stroke cognitive impairment is associated with vascular imaging pathology: a prospective observationa study
BMC Geriatr., 21 (1), 362
DOI 10.1186/s12877-021-02327-2
The Impact of Vascular Risk Factors on Post-stroke Cognitive Impairment: The Nor-COAST Study
Front. Neurol., 12, 678794
DOI 10.3389/fneur.2021.678794
Publications 2020
Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer's Disease in a Memory Clinic Cohort
J. Alzheimers Dis., 77 (2), 831-842
DOI 10.3233/JAD-200237
Is long-bout sedentary behaviour associated with long-term glucose levels 3 months after acute ischaemic stroke? A prospective observational cohort study
BMJ Open, 10 (11), e037475
DOI 10.1136/bmjopen-2020-037475
Enhancing mitophagy as a therapeutic approach for neurodegenerative diseases
Int. Rev. Neurobiol., 155, 169-202
DOI 10.1016/bs.irn.2020.02.008
A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease
Alzheimers Dement.-Diagn. Assess. Dis. Monit., 12 (1), e12128
DOI 10.1002/dad2.12128
The Association Between Circulating Inflammatory Markers and the Progression of Alzheimer Disease in Norwegian Memory Clinic Patients With Mild Cognitive Impairment or Dementia
Alzheimer Dis. Assoc. Dis., 34 (1), 47-53
DOI 10.1097/WAD.0000000000000342
Cerebrospinal fluid sTREM2 in Alzheimer's disease: comparisons between clinical presentation and AT classification
Sci Rep, 10 (1), 15886
DOI 10.1038/s41598-020-72878-8
Time from dementia diagnosis to nursing-home admission and death among persons with dementia: A multistate survival analysis
PLoS One, 15 (12), e0243513
DOI 10.1371/journal.pone.0243513
Cerebrospinal Fluid Levels of Interleukin-8 in Delirium, Dementia, and Cognitively Healthy Patients
J. Alzheimers Dis., 73 (4), 1363-1372
DOI 10.3233/JAD-190941
European Academy for medicine of ageing session participants' report on malnutrition assessment and diagnostic methods; an international survey
Clin. Nutr. ESPEN, 35, 75-80
DOI 10.1016/j.clnesp.2019.11.007
Post-stroke Cognitive Impairment-Impact of Follow-Up Time and Stroke Subtype on Severity and Cognitive Profile: The Nor-COAST Study
Front. Neurol., 11, 699
DOI 10.3389/fneur.2020.00699
Publications 2019
Cortisol levels among older people with and without depression and dementia
Int. Psychogeriatr., 31 (4), 597-601
DOI 10.1017/S1041610218001199
Adaptive Computerized Working Memory Training in Patients With Mild Cognitive Impairment. A Randomized Double-Blind Active Controlled Trial
Front. Psychol., 10, 807
DOI 10.3389/fpsyg.2019.00807
Cognitive Profiles and Atrophy Ratings on MRI in Senior Patients With Mild Cognitive Impairment (vol 10, 384, 2018)
Front. Aging Neurosci., 11, 37
DOI 10.3389/fnagi.2019.00037
The Effect of Changing the Amyloid beta(42) Cut-off of Cerebrospinal Fluid Biomarkers on Alzheimer Disease Diagnosis in a Memory Clinic Population in Norway
Alzheimer Dis. Assoc. Dis., 33 (1), 72-74
DOI 10.1097/WAD.0000000000000268
Study protocol: ASCRIBED: the impact of Acute SystematiC inflammation upon cerebRospinal fluId and blood BiomarkErs of brain inflammation and injury in dementia: a study in acute hip fracture patients
BMC Neurol., 19 (1), 223
DOI 10.1186/s12883-019-1447-7
Amyloid-beta PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer's disease diagnosis in a memory clinic
PLoS One, 14 (8), e0221365
DOI 10.1371/journal.pone.0221365
Higher Vitamin D Levels are Associated with Better Attentional Functions: Data from the NorCog Register
J. Nutr. Health Aging, 23 (8), 725-731
DOI 10.1007/s12603-019-1220-z
The Loss in Expectation of Life due to Early-Onset Mild Cognitive Impairment and Early-Onset Dementia in Norway
Dement. Geriatr. Cogn. Disord., 47 (4-6), 355-365
DOI 10.1159/000501269
Publications 2018
Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics
J. Alzheimers Dis., 61 (3), 1221-1232
DOI 10.3233/JAD-170436
Association between vascular comorbidity and progression of Alzheimer's disease: a two-year observational study in Norwegian memory clinics
BMC Geriatr., 18, 120
DOI 10.1186/s12877-018-0813-4
Cognitive Profiles and Atrophy Ratings on MRI in Senior Patients With Mild Cognitive Impairment
Front. Aging Neurosci., 10, 384
DOI 10.3389/fnagi.2018.00384
Comparison of automated volumetry of the hippocampus using NeuroQuant (R) and visual assessment of the medial temporal lobe in Alzheimer's disease
Acta Radiol., 59 (8), 997-1001
DOI 10.1177/0284185117743778
Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway
PLoS One, 13 (9), e0204436
DOI 10.1371/journal.pone.0204436
The Norwegian Cognitive impairment after stroke study (Nor-COAST): study protocol of a multicentre, prospective cohort study
BMC Neurol., 18, 193
DOI 10.1186/s12883-018-1198-x
Publications 2017
Trajectories of depressive symptoms and their relationship to the progression of dementia
J. Affect. Disord., 222, 146-152
DOI 10.1016/j.jad.2017.07.008
Forgetful and forgotten
Tidsskr. Nor. Laegeforen., 137 (10), 685
DOI 10.4045/tidsskr.17.0388
Factors that influence the levels of cerebrospinal fluid biomarkers in memory clinic patients
BMC Geriatr., 17, 210
DOI 10.1186/s12877-017-0611-4
MRI-assessed atrophy subtypes in Alzheimer's disease and the cognitive reserve hypothesis
PLoS One, 12 (10), e0186595
DOI 10.1371/journal.pone.0186595
Publications 2016
Performance of Cerebrospinal Fluid Biomarkers of Alzheimer Disease in a Memory Clinic in Norway
Alzheimer Dis. Assoc. Dis., 30 (1), 8-14
DOI 10.1097/WAD.0000000000000126
Publications 2015
Confirmatory factor analysis of the Cornell scale for depression in dementia among patient with dementia of various degrees
J. Affect. Disord., 188, 173-178
DOI 10.1016/j.jad.2015.08.062
Publications 2014
Impaired cognition in depression and Alzheimer (AD): a gradient from depression to depression in AD
Arq. Neuro-Psiquiatr., 72 (9), 671-679
DOI 10.1590/0004-282X20140108
Prevalence of depression among memory clinic patients as measured by the Cornell Scale of Depression in Dementia
Aging Ment. Health, 18 (5), 579-587
DOI 10.1080/13607863.2013.827630
Publications 2013
A Comparison of the Cornell Scale for Depression in Dementia and the Montgomery-Aasberg Depression Rating Scale in a Memory Clinic Population
Dement. Geriatr. Cogn. Disord., 35 (5-6), 256-265
DOI 10.1159/000348345
A cross-cultural comparison of the phenotype of depression as measured by the Cornell Scale and the MADRS in two elderly outpatient populations
J. Affect. Disord., 144 (1-2), 34-41
DOI 10.1016/j.jad.2012.06.003
Publications 2012
Validation of Montgomery-Asberg Rating Scale and Cornell Scale for Depression in Dementia in Brazilian elderly patients
Int. Psychogeriatr., 24 (8), 1291-1298
DOI 10.1017/S1041610211002250
Publications 2011
A Comparison of the Validity of the Cornell Scale and the MADRS in Detecting Depression among Memory Clinic Patients
Dement. Geriatr. Cogn. Disord., 32 (4), 287-294
DOI 10.1159/000334983